ATH 0.00% 0.3¢ alterity therapeutics limited

SRPT Duchenne Drug trial hits 5 year mark, page-27

  1. 9 Posts.
    xrx2gr0 I think you may be stretching for negatives now. Yes an online newsletter included an incorrect attribution. OK.

    I'm not worried about marketing versus the big boys. Or manufacturing. Or distribution. Those things will solve themselves as there will be ready queue of capable firms and experienced professionals eager to work with a small pharma with an approved drug for HD or AD. My concerns are purely about getting trials (HD, AD and PD) designed, funded and underway somewhere where they can be registered and move forward so we can get to that point.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $7.879K 2.590M

Buyers (Bids)

No. Vol. Price($)
58 79758033 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 1157860 1
View Market Depth
Last trade - 15.57pm 17/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.